Austin Community Comes Together
to Raise $75,000 for CureDuchenne at Annual Ladies Luncheon

Palm Springs-themed Event Supports Global Nonprofit Focused on Finding and Funding a Cure for Duchenne Muscular Dystrophy

NEWPORT BEACH, Calif., (September 23, 2022) – CureDuchenne, a leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, held the annual Ladies Luncheon at the Austin Country Club on Wednesday, September 14, 2022. Started by Austin residents Tim and Laura Revell, this year’s Ladies Luncheon event was hosted by Venus Strawn and Jennifer Stevens, who gathered Austin’s most influential women to raise vital funds for a cure for Duchenne muscular dystrophy. At this year’s event, themed “An Afternoon in Palm Springs,” attendees journeyed back to the glam days of Hollywood’s desert oasis for dining, big hats and bubbly with inspiring speakers, raffles and opportunities to network. TV host, entertainment reporter and former Miss Texas USA Holly Mills-Gardner emceed the event.

At just two and five years old, Tim and Laura Revell’s sons, Timothy and Andrew, were diagnosed with Duchenne, the most common and severe form of muscular dystrophy. With little known about the disease and few treatments available, the Revells connected with CureDuchenne for resources. Since then, Tim and Laura have created marathons, galas and the annual Ladies Luncheon fundraising events all in an effort to raise awareness of the disease and funds for CureDuchenne.

“We’ve fought to change the outcomes for people living with Duchenne since Timothy and Andrew’s diagnoses, and we are humbled by the support we have seen from our friends in the Austin community,” said Laura Revell. “Tim and I are on a mission–our goal is to cure Duchenne, to help those receiving the death sentence that our own family has received, twice. Tim and I support CureDuchenne because they are truly advancing the science that will lead to a cure. When our community comes together, we will have the absolute best chance of finding effective treatments for our boys and thousands more like them.”

Duchenne muscular dystrophy is a fatal genetic disease that affects roughly 1 in 5,000 male births. Individuals with Duchenne are typically diagnosed as toddlers, lose the ability to walk in their early-teens and often succumb to the disease in their mid-20s. Since CureDuchenne was founded in 2003, the organization has raised more than $50 million for research and funded 16 research projects that have advanced to human clinical trials. In addition, CureDuchenne develops impactful programs that help families living with Duchenne around the world.

“We are immensely grateful to Tim, Laura, Jennifer, Venus and the entire Austin community, for their unwavering commitment to CureDuchenne,” said Debra Miller, Founder and CEO of CureDuchenne. “We are at a critical point for Duchenne research, and this event provides crucial funding as we work toward a cure for Tim and Laura’s children, my son, and thousands more with Duchenne around the world.”

Sponsors of this year’s Ladies Luncheon event included Diamonds Direct, Diptyque Paris, Neiman Marcus, Premiere Events, CassandraCollections and i3 Event Marketing.

About CureDuchenne
CureDuchenne is recognized as a global leader in research, patient care and innovation for improving and extending the lives of those with Duchenne muscular dystrophy. As the leading genetic killer of young boys, Duchenne affects more than 300,000 individuals living today. CureDuchenne is dedicated to finding and funding a cure for Duchenne by breaking the traditional charitable mold through an innovative venture philanthropy model that funds groundbreaking research, early diagnosis, and community education. For more information on how to help raise awareness and funds needed for research, please visit

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.